{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T23:10:16Z","timestamp":1766013016756,"version":"3.37.3"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000848","name":"University of Edinburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/P020267\/1"],"award-info":[{"award-number":["EP\/P020267\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>An upcoming trial may provide further evidence that adolescent\/adult-targeted BCG revaccination prevents sustained Mycobacterium tuberculosis infection, but its public health value depends on its impact on overall tuberculosis morbidity and mortality, which will remain unknown. Using previously calibrated models for India and South Africa, we simulated BCG revaccination assuming 45% prevention-of-infection efficacy, and we evaluated scenarios varying additional prevention-of-disease efficacy between +50% (reducing risk) and \u221250% (increasing risk). Given the assumed prevention-of-infection efficacy and range in prevention-of-disease efficacy, BCG revaccination may have a positive health impact and be cost-effective. This may be useful when considering future evaluations and implementation of adolescent\/adult BCG revaccination.<\/jats:p>","DOI":"10.1093\/infdis\/jiae089","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T18:07:21Z","timestamp":1712167641000},"page":"e139-e143","source":"Crossref","is-referenced-by-count":4,"title":["Estimating the Potential Public Health Value of BCG Revaccination"],"prefix":"10.1093","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8923-0301","authenticated-orcid":false,"given":"Rebecca A","family":"Clark","sequence":"first","affiliation":[{"name":"TB Modelling Group and TB Centre, London School of Hygiene & Tropical Medicine , London , United Kingdom"},{"name":"Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine , London , United Kingdom"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine , London , United Kingdom"},{"name":"Vaccine Centre, London School of Hygiene & Tropical Medicine , London , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9305-534X","authenticated-orcid":false,"given":"Tom","family":"Sumner","sequence":"additional","affiliation":[{"name":"TB Modelling Group and TB Centre, London School of Hygiene & Tropical Medicine , London , United Kingdom"},{"name":"Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine , London , United Kingdom"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine , London , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7364-1026","authenticated-orcid":false,"given":"Chathika K","family":"Weerasuriya","sequence":"additional","affiliation":[{"name":"TB Modelling Group and TB Centre, London School of Hygiene & Tropical Medicine , London , United Kingdom"},{"name":"Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine , London , United Kingdom"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine , London , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1958-0944","authenticated-orcid":false,"given":"Roel","family":"Bakker","sequence":"additional","affiliation":[{"name":"TB Modelling Group and TB Centre, London School of Hygiene & Tropical Medicine , London , United Kingdom"},{"name":"Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine , London , United Kingdom"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine , London , United Kingdom"},{"name":"KNCV Tuberculosis Foundation , Division TB Elimination and Health System Innovations, the Hague , the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0641-1359","authenticated-orcid":false,"given":"Thomas J","family":"Scriba","sequence":"additional","affiliation":[{"name":"South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Cape Town , South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4410-6635","authenticated-orcid":false,"given":"Richard G","family":"White","sequence":"additional","affiliation":[{"name":"TB Modelling Group and TB Centre, London School of Hygiene & Tropical Medicine , London , United Kingdom"},{"name":"Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine , London , United Kingdom"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine , London , United Kingdom"},{"name":"Vaccine Centre, London School of Hygiene & Tropical Medicine , London , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,4,3]]},"reference":[{"author":"World Health Organization","key":"2024072520134415200_jiae089-B1"},{"key":"2024072520134415200_jiae089-B2","doi-asserted-by":"crossref","first-page":"e546","DOI":"10.1016\/S2214-109X(23)00045-1","article-title":"The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study","volume":"11","author":"Clark","year":"2023","journal-title":"Lancet Glob Health"},{"key":"2024072520134415200_jiae089-B3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12916-023-02992-7","article-title":"New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent\/adult vaccination with M72\/AS01E and BCG-revaccination","volume":"21","author":"Clark","year":"2023","journal-title":"BMC Med"},{"key":"2024072520134415200_jiae089-B4","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.vaccine.2024.01.072","article-title":"Modelling the health and economic impacts of M72\/AS01E vaccination and BCG-revaccination: estimates for South Africa","volume":"42","author":"Sumner","year":"2024","journal-title":"Vaccine"},{"key":"2024072520134415200_jiae089-B5","doi-asserted-by":"crossref","first-page":"e1004155","DOI":"10.1371\/journal.pmed.1004155","article-title":"The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: a modeling study","volume":"20","author":"Portnoy","year":"2023","journal-title":"PLoS Med"},{"key":"2024072520134415200_jiae089-B6","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41467-022-28234-7","article-title":"Cost-effectiveness of routine adolescent vaccination with an M72\/AS01E-like tuberculosis vaccine in South Africa and India","volume":"13","author":"Harris","year":"2022","journal-title":"Nat Commun"},{"key":"2024072520134415200_jiae089-B7","doi-asserted-by":"crossref","first-page":"eaax4607","DOI":"10.1126\/scitranslmed.aax4607","article-title":"Potential impact of tuberculosis vaccines in China, South Africa, and India","volume":"12","author":"Harris","year":"2020","journal-title":"Sci Transl Med"},{"author":"World Health Organization","key":"2024072520134415200_jiae089-B8"},{"key":"2024072520134415200_jiae089-B9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis infection with H4:1C31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"},{"author":"Bill & Melinda Gates Medical Research Institute","key":"2024072520134415200_jiae089-B10"},{"key":"2024072520134415200_jiae089-B11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2213-2600(17)30060-7","article-title":"Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study","volume":"5","author":"Andrews","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024072520134415200_jiae089-B12","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/thoraxjnl-2017-211147","article-title":"Stratification by interferon-\u03b3 release assay level predicts risk of incident TB","volume":"73","author":"Winje","year":"2018","journal-title":"Thorax"},{"key":"2024072520134415200_jiae089-B13","doi-asserted-by":"crossref","first-page":"e1307","DOI":"10.1016\/S2214-109X(22)00283-2","article-title":"Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis","volume":"10","author":"Martinez","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2024072520134415200_jiae089-B14","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"The Lancet"},{"key":"2024072520134415200_jiae089-B15","doi-asserted-by":"crossref","first-page":"e000964","DOI":"10.1136\/bmjgh-2018-000964","article-title":"Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data","volume":"3","author":"Ochalek","year":"2018","journal-title":"BMJ Glob Health"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiae089\/57146264\/jiae089.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/230\/1\/e139\/58649895\/jiae089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/230\/1\/e139\/58649895\/jiae089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T20:18:27Z","timestamp":1721938707000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/230\/1\/e139\/7639736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,3]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,4,3]]},"published-print":{"date-parts":[[2024,7,25]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiae089","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"type":"print","value":"0022-1899"},{"type":"electronic","value":"1537-6613"}],"subject":[],"published-other":{"date-parts":[[2024,7,15]]},"published":{"date-parts":[[2024,4,3]]}}}